OPEN CFDA 12.420 ↗ Competitive Cooperative Agreement Hard ~100h to apply

DoW Breast Cancer, Transformative Breast Cancer Consortium Award

🏛 Dept. of the Army -- USAMRAA (DOD-AMRAA)

⏰ Deadline
Sep 30, 2026 in 109 days
📊 Total program funding
$35M
🎯 Expected awards
1 recipient
📍 Scope
National
📨 Letter of Intent
Yesrequired first

Can you apply?

This grant is for researchers developing transformative, multi-institutional breast cancer research consortia. Eligible applicants include universities, research institutes, medical centers, and cancer organizations with strong research capabilities. The consortium must include multiple principal investigators (up to five total), clinicians, scientists, and at least one breast cancer consumer advocate per project team. Applications must address a major breast cancer challenge that requires collaboration across institutions to solve.

Eligible applicants
Check your eligibility — what type of organization are you?

Program description

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Award supports collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate progress toward ending breast cancer. Applications must propose a synergistic, highly integrated, multidisciplinary and multi-institutional consortium of leading scientists, clinicians and breast cancer consumer advocates that will address a major problem in a way that a single investigator or group could not accomplish. The consortium’s collaborative efforts must make a transformative impact in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. If the application addresses a different fundamental issue, the application must couple it with at least one of the overarching challenges.

Distinctive Features: This funding mechanism allows for up to five Principal Investigators (PIs) which includes the Consortium Director and three or four Project Team PIs. Applications must include at least one breast cancer consumer advocate per project team. Only the Consortium Director will submit a pre-application, but all PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Consortium Director and Project Team PIs) applications by the full application deadline may result in administrative withdrawal.

Who can apply

Eligible applicants

Demographic focus

How to apply

Application links

Key dates & requirements

  • 📄 Narrative page limit: 45 pages
  • Project period: 48 months
  • 🧾 Budget narrative required. Free budget template →
  • 📨 Letter of Intent due: Jun 12, 2026

Required documents

  • SF-424 (Federal Application for Grants and Cooperative Agreements)
  • Project Narrative/Research Plan
  • Budget and Budget Justification
  • Biographical Sketches (all PIs)
  • Supporting Documents (letters of commitment, institutional support)

Program contact

  • 👤 Jamie Shortall Grant Officer
  • 📧 help@eBRAP.org
  • 📞 301-619-2393

Funding track record

Recent awards under CFDA 12.420 from the last 3 years — real organizations that won funding through this same program.

100
awards (3 yrs)
$4.3B
total funded
68
unique recipients
$42.7M
average award

Top 10 Largest Recent Awards

  1. $2,265,729,366
  2. $800,631,761
  3. $74,531,880
  4. $67,205,571
  5. $53,718,832
  6. $34,191,124
  7. $24,907,742
  8. $21,394,379
  9. $19,100,256
  10. $19,002,641

Top States by Funding

  • MD 10 awards $3,150.1M
  • NC 11 awards $132.3M
  • FL 8 awards $99.8M
  • CA 11 awards $99.3M
  • MA 7 awards $75.2M

Source: USAspending.gov — federal spending transparency. Data covers last 3 years.

Funding history

Annual funding for this program — Federal obligations (CFDA 12.420). How funding has trended year over year.

2024 $1,483,968,520
2025 $1,201,153,417

FAQ

Who can serve as principal investigators?

Up to five PIs are allowed, including one Consortium Director and three to four Project Team PIs. All PIs must submit full applications.

Do I need to include consumer advocates?

Yes. Each project team must include at least one breast cancer consumer advocate as a required team member.

What is the deadline?

The deadline is September 30, 2026. Only the Consortium Director submits a pre-application; all PIs submit at the full application stage.

Must my research address Army priorities?

Applications must address at least one FY26 BCRP overarching challenge, or provide strong justification if addressing a different fundamental issue.

Is cost sharing required?

No. Cost sharing is not a requirement for this funding mechanism.

💡 Tips for applicants

  • Assemble your consortium team early. Identify complementary expertise across institutions before writing.
  • Include a strong consumer advocate voice from the beginning of planning, not as an afterthought.
  • Ensure all PIs are ready to submit their individual applications by the September 2026 deadline.
  • Clearly articulate how your consortium's collaboration addresses a problem a single group cannot solve alone.
  • Link your research explicitly to at least one FY26 BCRP overarching challenge, or clearly justify any exception.

⚠️ Common mistakes

Applications fail to include required consumer advocates on project teams. Insufficient emphasis on the synergistic, transformative value of the multi-institutional consortium model. Incomplete submissions when not all PIs submit applications by the deadline.

Similar grants

109 days left Sep 30, 2026
Apply →